Oncology/Hematology Market Research Reports & Industry Analysis
Oncology/Hematology Industry Research & Market Reports
-
Global Bispecific Antibodies Market Size Study & Forecast, by Indication (Cancer, Inflammatory & Autoimmune Disorders, Others), and Regional Analysis, 2023-2030
... anticipated to grow with a healthy growth rate of more than 44.0% over the forecast period 2023-2030. Bispecific antibodies are a class of therapeutic proteins created to attach to two distinct target molecules simultaneously. These ... Read More
-
Fallopian Tube Cancer Market Outlook to 2030- Forecasts of Market Size, Share, Companies, Countries, Trends, Opportunities, and Industry Developments Report
... to register an optimistic growth between 2024 and 2030. Robust demand from end-user industries, widening applications, and investments in new technologies support the long-term market growth potential. The late-2023 edition- “Fallopian Tube Cancer Market Outlook ... Read More
-
Endometrial Cancer Market Outlook to 2030- Forecasts of Market Size, Share, Companies, Countries, Trends, Opportunities, and Industry Developments Report
... an optimistic growth between 2024 and 2030. Robust demand from end-user industries, widening applications, and investments in new technologies support the long-term market growth potential. The late-2023 edition- “Endometrial Cancer Market Outlook to 2030- Forecasts ... Read More
-
Hairy Cell Leukemia Therapeutics Market by Product Type (Chemotherapy Drug, Immunotherapy Drug), Distribution Channel (Cancer Research Organization, Hospitals, Long Term Care Centers) - Global Forecast 2023-2030
... at USD 164.07 million in 2022 and expected to reach USD 177.88 million in 2023, at a CAGR 8.55% to reach USD 316.39 million by 2030. Market Segmentation & Coverage: This research report analyzes various ... Read More
-
Melanoma Drug Market by Type of Melanoma (Acral Lentiginous Melanoma, Lentigo Maligna Melanoma, Nodular Melanoma), Therapy (Chemotherapy, Immunotherapy, Targeted Therapy) - Global Forecast 2023-2030
... in 2022 and expected to reach USD 5.53 billion in 2023, at a CAGR 13.35% to reach USD 13.32 billion by 2030. Market Segmentation & Coverage: This research report analyzes various sub-markets, forecasts revenues, and ... Read More
-
Nasopharyngeal Cancer Market Outlook to 2030- Forecasts of Market Size, Share, Companies, Countries, Trends, Opportunities, and Industry Developments Report
... an optimistic growth between 2024 and 2030. Robust demand from end-user industries, widening applications, and investments in new technologies support the long-term market growth potential. The late-2023 edition- “Nasopharyngeal Cancer Market Outlook to 2030- Forecasts ... Read More
-
Global Non-Small Cell Lung Cancer Market Professional Survey by Types, Applications, and Players, with Regional Growth Rate Analysis and Development Situation, from 2023 to 2028
... market growth of the Non-Small Cell Lung Cancer industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Non-Small Cell Lung Cancer. The report ... Read More
-
In Vitro Diagnostics Market By Product and Services (Reagents and Kits, Instruments, Software and Services), By Technique (Immunodiagnostics, Hematology, Molecular Diagnostics, Tissue Diagnostics, Clinical Chemistry, Others), By Application (Infectious Diseases, Cancer, Cardiac Diseases, Immune System Disorders, Nephrological Diseases, Gastrointestinal Diseases, Others), By End User (Standalone Laboratories, Hospitals, Academic and Medical Schools, Point of Care, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032
... Disorders, Nephrological Diseases, Gastrointestinal Diseases, Others), By End User (Standalone Laboratories, Hospitals, Academic and Medical Schools, Point of Care, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032 The in vitro diagnostics market was valued at ... Read More
-
China Oncology Drugs Market, Size, Forecast 2024-2028, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis
... Research. There has been an alarming increase in China’s oncology drugs prices during the last 30 years. China is now the second biggest pharmaceutical market in the world. The Chinese biopharmaceutical enterprise presently processes a ... Read More
-
Small Cell Lung Cancer Therapeutics
... to the pharmaceutical and biotechnology sector focused on the development, production, and sale of medications and treatments for small cell lung cancer. SCLC is a type of lung cancer that tends to grow and spread ... Read More
-
Digital Marketing Trends in Colorectal Cancer
... by BMS’s Opdivo.com (1.7 million visits) and Roche’s Avastin.com (258,000 visits). Overall, the highest proportion of traffic to top branded patient CRC websites originated from direct sources, followed by organic. Merck’s Keytruda.com had the highest ... Read More
-
Chronic Lymphocytic Leukemia (CLL) Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032
... the disease epidemiology and 10-year patient-based forecast (PBF) across the 8MM for marketed and late-stage pipeline therapies, with a launch date assessment by market for Chronic Lymphocytic Leukemia (CLL). These sales forecasts leverage data on ... Read More
-
Radioactive Tracer Market, By Type (Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers, Others), By Application (Oncology, Cardiology, Neurology, Thyroid, Lymphoma, Endocrinology, Others), By End User (Hospitals, Diagnostic Centers, Cancer Research Institutes, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... Latin America, Europe, Asia Pacific, Middle East & Africa) Radioactive Tracer Market, By Type (Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers, Others), By Application (Oncology, Cardiology, Neurology, Thyroid, Lymphoma, Endocrinology, Others), By End User (Hospitals, Diagnostic ... Read More
-
Acute Myeloid Leukemia (AML) Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032
... of the disease epidemiology and 10-year patient-based forecast (PBF) across the 8MM for marketed and late-stage pipeline therapies, with a launch date assessment by market for Acute Myeloid Leukemia (AML). These sales forecasts leverage data ... Read More
-
Global Penile Cancer Treatment Market - 2023-2030
... during the forecast period 2023-2030. The penile cancer treatment market is driven by factors such as increasing incidence of penile cancer, advancements in treatment options, awareness, and early detection, supportive government initiatives, increasing healthcare expenditure, ... Read More
-
2023-2027 Finland Breast Cancer Diagnostics Market - CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor - Country Database and Analysis - Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
... Emerging Technologies, Latest Instrumentation, Growth Opportunities This new report from LeadingMarketResearch.com . This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding breast ... Read More
-
2023-2027 Netherlands Breast Cancer Diagnostics Market - CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor - Country Database and Analysis - Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
... Emerging Technologies, Latest Instrumentation, Growth Opportunities This new report from LeadingMarketResearch.com . This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding breast ... Read More
-
2023-2027 Pakistan Breast Cancer Diagnostics Market - CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor - Country Database and Analysis - Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
... Emerging Technologies, Latest Instrumentation, Growth Opportunities This new report from LeadingMarketResearch.com . This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding breast ... Read More
-
2023-2027 Puerto Rico Breast Cancer Diagnostics Market - CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor - Country Database and Analysis - Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
... Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities This new report from LeadingMarketResearch.com . This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding ... Read More
-
2023-2027 World Breast Cancer Diagnostics Market - CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor - A 92-Country Database and Analysis, Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
... Emerging Technologies, Latest Instrumentation, Growth Opportunities This new 92-country report from LeadingMarketResearch.com This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding breast ... Read More
-
2023-2027 Uruguay Breast Cancer Diagnostics Market - CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor - Country Database and Analysis - Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
... Emerging Technologies, Latest Instrumentation, Growth Opportunities This new report from LeadingMarketResearch.com . This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding breast ... Read More
-
2023-2027 Brazil Breast Cancer Diagnostics Market - CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor - Country Database and Analysis - Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
... Emerging Technologies, Latest Instrumentation, Growth Opportunities This new report from LeadingMarketResearch.com . This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding breast ... Read More
-
2023-2027 Russia Breast Cancer Diagnostics Market - CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor - Country Database and Analysis - Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
... Emerging Technologies, Latest Instrumentation, Growth Opportunities This new report from LeadingMarketResearch.com . This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding breast ... Read More
-
2023-2027 Argentina Breast Cancer Diagnostics Market - CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor - Country Database and Analysis - Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
... Emerging Technologies, Latest Instrumentation, Growth Opportunities This new report from LeadingMarketResearch.com . This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding breast ... Read More
-
2023-2027 Estonia Breast Cancer Diagnostics Market - CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor - Country Database and Analysis - Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
... Emerging Technologies, Latest Instrumentation, Growth Opportunities This new report from LeadingMarketResearch.com . This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding breast ... Read More
Research Assistance
